Investors ready to resuscitate Johnson & Johnson’s ailing stock
Johnson & Johnson (JNJ.N) shareholders have endured a painful year amid worries about prospects for its many businesses, but investors capitalizing on the stock’s relatively cheap valuation may be set to apply a Band-Aid to the declines. Shares of J&J, the largest U.S. healthcare company by market value, had slumped 11.2 percent this year as of Friday’s close, although recent gains may indicate the start of a rebound. The stock’s year-to-date decline compares to more than 2 percent gains for both the S&P 500 healthcare sector (.SPXHC) and the blue chip Dow Jones Industrial Average (.DJI), of which J&J is a member.
Source:: https://finance.yahoo.com/news/investors-ready-resuscitate-johnson-johnsons-182118905.html
